Trial Outcomes & Findings for Association of Acupuncture and Cupping in Advanced Knee Osteoarthritis (NCT NCT04168593)
NCT ID: NCT04168593
Last Updated: 2025-03-27
Results Overview
Western Ontario and McMaster Universities Osteoarthritis Womac-Pain section. Score: 0 (no pain) to 20 (worse condition)
COMPLETED
NA
120 participants
value collected at 5 week
2025-03-27
Participant Flow
recruitment by phone from a list of patients with advanced KOA who is waiting for a TKR. the inclusion criteria is applied.
by phone we applied the WOMAC-Pain and invite who have 15 points or more
Participant milestones
| Measure |
A- Acupuncture Sham + Cupping Sham
Sham acupuncture: Placement of placebo "dagger" needles. The needle tip, when touching the patient's skin, retracts into itself without puncturing the skin. Application locations: LI11, SP9, SP10, LR8, GB34, ST34, Ex-LE5. Running time of 20 minutes.
Sham cupping: after each acupuncture session (Sham or True), the respective needles were removed, and acrylic suction cups were placed over the region where the needles were, attached to a strip (micropore) without exerting any negative pressure or movement. Application time of 10 minutes.
|
B -Sham Acupuncture + Real Cupping
Acupuncture 20 min of Acupuncture section follow by 10 min of cupping around the knee
|
C - Real Acupuncture + Sham Cupping
20 min of Acupuncture section follow by 10 min of cupping around the knee
|
D - Real Acupuncture + Real Cupping
20 min of Acupuncture section follow by 10 min of cupping around the knee
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
30
|
30
|
30
|
30
|
|
Overall Study
COMPLETED
|
26
|
28
|
27
|
29
|
|
Overall Study
NOT COMPLETED
|
4
|
2
|
3
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
A- Placebo
n=30 Participants
Sham Acupuncture and Sham Cupping
20 min of Acupuncture section using placebo needle follow by 10 min of cupping sham (no negative pressure) around the knee
|
B -Cupping
n=30 Participants
Sham Acupuncture and Real Cupping
20 min of Acupuncture section using placebo needle follow by 10 min of real cupping around the knee
|
C - Acupuncture
n=30 Participants
Real Acupuncture and Sham Cupping
20 min of Real Acupuncture section follow by 10 min of sham cupping around the knee
|
D - Acupuncture + Cupping
n=30 Participants
Real Acupuncture and Real Cupping
20 min of Real Acupuncture section follow by 10 min of real cupping around the knee
|
Total
n=120 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|
|
Age, Customized
Age distribution
|
66.1 years
STANDARD_DEVIATION 10.88 • n=30 Participants
|
66.1 years
STANDARD_DEVIATION 10.86 • n=30 Participants
|
68.1 years
STANDARD_DEVIATION 11.15 • n=30 Participants
|
66.8 years
STANDARD_DEVIATION 8.09 • n=30 Participants
|
66.8 years
STANDARD_DEVIATION 10.17 • n=120 Participants
|
|
Sex: Female, Male
Female
|
21 Participants
n=30 Participants
|
23 Participants
n=30 Participants
|
23 Participants
n=30 Participants
|
25 Participants
n=30 Participants
|
92 Participants
n=120 Participants
|
|
Sex: Female, Male
Male
|
9 Participants
n=30 Participants
|
7 Participants
n=30 Participants
|
7 Participants
n=30 Participants
|
5 Participants
n=30 Participants
|
28 Participants
n=120 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
Brazil
|
30 participants
n=30 Participants
|
30 participants
n=30 Participants
|
30 participants
n=30 Participants
|
30 participants
n=30 Participants
|
120 participants
n=120 Participants
|
|
WOMAC-Pain
|
16.83 units on a scale
STANDARD_DEVIATION 1.74 • n=30 Participants
|
16.50 units on a scale
STANDARD_DEVIATION 1.38 • n=30 Participants
|
16.40 units on a scale
STANDARD_DEVIATION 1.43 • n=30 Participants
|
16.90 units on a scale
STANDARD_DEVIATION 1.75 • n=30 Participants
|
16.66 units on a scale
STANDARD_DEVIATION 1.58 • n=120 Participants
|
|
VAS
|
84.03 units on a scale
STANDARD_DEVIATION 13.75 • n=30 Participants
|
89.57 units on a scale
STANDARD_DEVIATION 11.81 • n=30 Participants
|
82.83 units on a scale
STANDARD_DEVIATION 12.97 • n=30 Participants
|
91.30 units on a scale
STANDARD_DEVIATION 11.43 • n=30 Participants
|
89.92 units on a scale
STANDARD_DEVIATION 12.88 • n=120 Participants
|
PRIMARY outcome
Timeframe: value collected at 5 weekPopulation: We used the concept of Intent to Treat (ITT) for statistical analysis purposes, that is, all recruited participants, even if they did not complete the proposed 10-session treatment, were included in the final analysis
Western Ontario and McMaster Universities Osteoarthritis Womac-Pain section. Score: 0 (no pain) to 20 (worse condition)
Outcome measures
| Measure |
Group A
n=30 Participants
Sham Acupuncture + Sham Cupping
|
Group B
n=30 Participants
Sham Acupuncture + Real Cupping
|
Group C
n=30 Participants
Real Acupuncture + Sham Cupping
|
Group D
n=30 Participants
Real Acupuncture + Real Cupping
|
Group D
Real Acupuncture + Real Cupping
|
|---|---|---|---|---|---|
|
WOMAC - Pain
|
11.60 units on a scale
Standard Deviation 4.17
|
11.30 units on a scale
Standard Deviation 4.23
|
10.80 units on a scale
Standard Deviation 4.64
|
9.83 units on a scale
Standard Deviation 4.76
|
—
|
PRIMARY outcome
Timeframe: Value collected at 5 weeksPopulation: We used the concept of Intent to Treat (ITT) for statistical analysis purposes, that is, all recruited participants, even if they did not complete the proposed 10-session treatment, were included in the final analysis.
Intensity of pain 0-100 mm (0 corresponds to a better condition, otherwise, 100 correspond to a worst condition of pain)
Outcome measures
| Measure |
Group A
n=30 Participants
Sham Acupuncture + Sham Cupping
|
Group B
n=30 Participants
Sham Acupuncture + Real Cupping
|
Group C
n=30 Participants
Real Acupuncture + Sham Cupping
|
Group D
n=30 Participants
Real Acupuncture + Real Cupping
|
Group D
Real Acupuncture + Real Cupping
|
|---|---|---|---|---|---|
|
VAS
|
67.43 units on a scale
Standard Deviation 23.09
|
61.57 units on a scale
Standard Deviation 25.57
|
47.87 units on a scale
Standard Deviation 27.23
|
47.43 units on a scale
Standard Deviation 28.99
|
—
|
SECONDARY outcome
Timeframe: Number of Participants with reduction in the use of pain medications after protocol (at 5 week)Population: We used the concept of Intent to Treat (ITT) for statistical analysis purposes, that is, all recruited participants, even if they did not complete the proposed 10-session treatment, were included in the final analysis.
number of pills per day For each group, those who had a reduction in the use of pain medications (analgesics and/or anti-inflammatory drugs) we described as Y (yes), and those who maintained or even increased the amount or simply did not return such information we described as N (no).
Outcome measures
| Measure |
Group A
n=120 Participants
Sham Acupuncture + Sham Cupping
|
Group B
n=30 Participants
Sham Acupuncture + Real Cupping
|
Group C
n=30 Participants
Real Acupuncture + Sham Cupping
|
Group D
n=30 Participants
Real Acupuncture + Real Cupping
|
Group D
n=30 Participants
Real Acupuncture + Real Cupping
|
|---|---|---|---|---|---|
|
Analgesic Consumption
|
72 Participants
|
12 Participants
|
18 Participants
|
19 Participants
|
23 Participants
|
Adverse Events
Group A
Group B
Group C
Group D
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Group A
n=30 participants at risk
Sham + Sham
|
Group B
n=30 participants at risk
Sham Acp + Real Cupping
|
Group C
n=30 participants at risk
Real ACP + Sham Cupping
|
Group D
n=30 participants at risk
Real + Real
|
|---|---|---|---|---|
|
Skin and subcutaneous tissue disorders
hematoma
|
0.00%
0/30 • after 5 weeks from initial treatment
no serious adverse event, only local hematoma
|
3.3%
1/30 • after 5 weeks from initial treatment
no serious adverse event, only local hematoma
|
6.7%
2/30 • after 5 weeks from initial treatment
no serious adverse event, only local hematoma
|
6.7%
2/30 • after 5 weeks from initial treatment
no serious adverse event, only local hematoma
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place